Dextranomer/hyaluronic acid injections for patients with vesicoureteral reflux Does the age at injection predict the outcome?

ABSTRACT:

Introduction

We aimed to assess the impact of age of the initial dextranomer/hyaluronic acid (Dx/HA) injection on the subsequent outcome, including the need for repeated injections.

Methods

The charts of patients who underwent Dx/HA injection from 2010-2020 were retrospectively reviewed. Two groups were created according to the number of Dx/HA injections: single vs. repeated injections. Patients who presented with antenatal hydronephrosis, neurogenic bladder, and followup less than one year after the first injection were excluded. Repeated Dx/HA injections were indicated in patients with documented vesicoureteric reflux (VUR) who experienced recurrent febrile urinary tract infection (fUTI) postoperatively.

Results

A total of 172 patients with 189 renal units were incl

SUBMITTER: Weber B 

PROVIDER: S-EPMC12517443 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature